loadpatents
name:-0.025412797927856
name:-0.01853609085083
name:-0.0004730224609375
Zarling; David A. Patent Filings

Zarling; David A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Zarling; David A..The latest application filed is for "mitochondria targeted cationic anti-oxidant compounds for prevention, therapy or treatment of hyper-proliferative disease, neoplasias and cancers".

Company Profile
0.19.19
  • Zarling; David A. - Menlo Park CA
  • Zarling; David A. - Melo Park CA
  • Zarling, David A. - Fremont CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Androgen induced oxidative stress inhibitors
Grant 9,023,837 - Basu , et al. May 5, 2
2015-05-05
Mitochondria Targeted Cationic Anti-oxidant Compounds For Prevention, Therapy Or Treatment Of Hyper-proliferative Disease, Neoplasias And Cancers
App 20130338110 - ZARLING; David A. ;   et al.
2013-12-19
Androgen Induced Oxidative Stress Inhibitors
App 20130210772 - Basu; Hirak S. ;   et al.
2013-08-15
Mitochondria targeted cationic anti-oxidant compounds for prevention, therapy or treatment of hyper-proliferative disease, neoplasias and cancers
Grant 8,466,130 - Zarling , et al. June 18, 2
2013-06-18
Mitochondria Targeted Cationic Anti-oxidant Compounds For Prevention, Therapy Or Treatment Of Hyper-proliferative Disease, Neoplasias And Cancers
App 20110059922 - Zarling; David A. ;   et al.
2011-03-10
Pharmaceutically Active Compositions Comprising Oxidative Stress Modulators (osm), New Chemical Entities, Compositions And Uses
App 20100297262 - Basu; Hirak S. ;   et al.
2010-11-25
Use of consensus sequences for targeted homologous gene isolation and recombination in gene families
App 20060228799 - Pati; Sushma ;   et al.
2006-10-12
Locked nucleic acid hybrids and methods of use
Grant 6,977,295 - Belotserkovskii , et al. December 20, 2
2005-12-20
In vivo homologous sequence targeting in cells
App 20050214944 - Zarling, David A. ;   et al.
2005-09-29
Lysozyme transgenic ungulates
App 20040231010 - Murray, James D. ;   et al.
2004-11-18
Use of consensus sequences for targeted homologous gene isolation and recombination in gene families
App 20040091885 - Pati, Sushma ;   et al.
2004-05-13
In vivo homologous sequence targeting in eukaryotic cells
App 20040019916 - Zarling, David A. ;   et al.
2004-01-29
Modulation of tumor cells using BER inhibitors in combination with a sensitizing agent and DSBR inhibitors
App 20030229004 - Zarling, David A. ;   et al.
2003-12-11
High-throughput gene cloning and phenotypic screening
App 20030124505 - Jain, Sarita Kumari ;   et al.
2003-07-03
In vivo homologous sequence targeting in cells
App 20030105039 - Zarling, David A. ;   et al.
2003-06-05
High-throughput gene cloning and phenotypic screening
App 20030082551 - Zarling, David A. ;   et al.
2003-05-01
Up-converting reporters for biological and other assays using laser excitation techniques
Grant 6,537,829 - Zarling , et al. March 25, 2
2003-03-25
Novel Antisense Inhibition Of Rad51
App 20020147161 - ZENG, HONG ;   et al.
2002-10-10
Locked nucleic acid hybrids and methods of use
App 20020094555 - Belotserkovskii, Boris P. ;   et al.
2002-07-18
Use of Rad51 inhibitors for p53 gene therapy
App 20020086840 - Zarling, David A. ;   et al.
2002-07-04
Up-converting reporters for biological and other assays using laser excitation techniques
Grant 6,399,397 - Zarling , et al. June 4, 2
2002-06-04
Enhanced targeting of DNA sequences by recombinase protein and single-stranded homologous DNA probes using DNA analog activation
App 20020061530 - Belotserkovskii, Boris P. ;   et al.
2002-05-23
Recombinase mediated gene chip detection
App 20010044107 - Zarling, David A. ;   et al.
2001-11-22
Up-converting reporters for biological and other assays
Grant 6,312,914 - Kardos , et al. No
2001-11-06
Up-converting reporters for biological and other assays
Grant 6,159,686 - Kardos , et al. December 12, 2
2000-12-12
Sequence alterations using homologous recombination
Grant 6,074,853 - Pati , et al. June 13, 2
2000-06-13
Up-converting reporters for biological and other assays using laser excitation techniques
Grant 5,891,656 - Zarling , et al. April 6, 1
1999-04-06
In vivo homologous sequence targeting in eukaryotic cells
Grant 5,763,240 - Zarling , et al. June 9, 1
1998-06-09
Up-converting reporters for biological and other assays using laser excitation techniques
Grant 5,736,410 - Zarling , et al. April 7, 1
1998-04-07
Up-converting reporters for biological and other assays using laser excitation techniques
Grant 5,698,397 - Zarling , et al. December 16, 1
1997-12-16
Up-converting reporters for biological and other assays using laser excitation techniques
Grant 5,674,698 - Zarling , et al. October 7, 1
1997-10-07
Diagnostic applications of double D-loop formation
Grant 5,670,316 - Sena , et al. September 23, 1
1997-09-23
In situ hybridization method
Grant 5,506,098 - Zarling , et al. April 9, 1
1996-04-09
Diagnostic applications of double D-loop formation
Grant 5,273,881 - Sena , et al. December 28, 1
1993-12-28
Process for nucleic acid hybridization and amplification
Grant 5,223,414 - Zarling , et al. June 29, 1
1993-06-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed